Proof-of-Mechanism Study of the Phosphodiesterase 10 Inhibitor RG7203 in Patients With Schizophrenia and Negative Symptoms

BACKGROUND: Reduced activation of dopamine D(1) receptor signaling may be implicated in reward functioning as a potential driver of negative symptoms in schizophrenia. Phosphodiesterase 10A (PDE10A), an enzyme that is highly expressed in the striatum, modulates both dopamine D(2)- and D(1)-dependent...

Descripción completa

Detalles Bibliográficos
Autores principales: Umbricht, Daniel, Abt, Markus, Tamburri, Paul, Chatham, Christopher, Holiga, Štefan, Frank, Michael J., Collins, Anne G.E., Walling, David P., Mofsen, Rick, Gruener, Daniel, Gertsik, Lev, Sevigny, Jeff, Keswani, Sanjay, Dukart, Juergen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Archival Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616307/
https://www.ncbi.nlm.nih.gov/pubmed/36324430
http://dx.doi.org/10.1016/j.bpsgos.2021.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616307/
https://www.ncbi.nlm.nih.gov/pubmed/36324430
http://dx.doi.org/10.1016/j.bpsgos.2021.03.001

Ejemplares similares